Editor’s Note:
This month’s issue highlights information from the annual American Public Health Association (APHA ) conference Among the interesting sessions we report on are one involving ethics and other on communications in our polarized post COVID world. We also revisit an interview with Tony McMichael on the health effects of climate change.
We continue to provide you with our crossword series, Notes on People, an overview of what we are reading from the public media, and upcoming events for epidemiologists. If you enjoy our crosswords, you’ll find the answers for last month’s puzzle on page 18.
Finally, don’t miss the Job Bank offerings this month. We have a huge number of job openings advertised both here and on our website. We continue to field inquiries from employers throughout the US and beyond
November 2022 • Volume Forty Three • Number Eleven
A monthlyupdatecovering people, events, research, and keydevelopments -2- Thoughtful Communication & Fostering Change in a Polarized, PostCOVID Society -4- Ethics: Decision Making Given Incomplete Info & Evolving Evidence -6- From the Archives “Spaceship Earth” – McNichael’s Vision & the Importance of Research on Health Effects of Climate Change -11- Crossword Puzzle -13- What We’re Reading -15- Notes on People -18- Near Term Epi Event Calendar -19- Marketplace Jobs & Events In This Issue
Thoughtful Communication and Fostering Change in a Polarized, Post-COVID Society:
Notes from APHA 2022
Author: Madeline M. Roberts, MPH, PhD
Earlier this month The American Public Health Association (APHA) celebrated their 150th anniversary at their Annual Meeting and Expo in Boston, Massachusetts. We enjoyed a discussion panel led by Brian Castrucci titled “Where Do We Go From Here An Interactive Discussion of Strategies to Build the Public Health Workforce from College to Commissioner.” Castrucci’s aim for the discussion was “looking at what’s happening in public health and where we’re going.” The panel covered all manner of crucial, timely topics from public health messaging to the political arena. Panelists included Zamir Brown, Daniel Dawes, Perry Halkitis, and Marissa J. Levine.
“How can we be more effective as a field for making the case for public health?”
Halkitis suggested that in public health and in medicine, “We tend depend too much on the notion that people make rational decisions all the time,” and challenged the premise that people are always rational operators. He made the case that, given certain conditions, even high self efficacy is insufficient to effect rational decisions (he offered the example of alcohol consumption and the potential impact on condom use). He advocated for a paradigm shift creating programming with the understanding that people are not perfect and not always rational.
Halkitis went on to pose the question that, even weeks after the APHA meeting, continues to resonate and stimulate our thinking: “How do we take public health paradigms and infuse them with the social conditions that people are living in, with the emotional lives that people
have, and how do we build programs that actually marry the rational with the emotional and the structural?”
Further regarding “making the case for public health,” Halkitis discussed how during the pandemic he was “most happy to go on the news programs that were going to challenge my views because those are the programs where my messaging needs to get across most effectively.” In our hyper polarized environment this is a needed perspective, for those in our field to look forward to and lean into respectfully engaging with the people and programs who hold opposing views.
Messaging and Public Health Leadership
A question was raised regarding how to navigate a deeply divided political landscape as a leader in terms of public health messaging. Levine responded, “One of the key leadership principles is that the good leader doesn’t have to have all the answers, but the good leader needs to have good questions and be willing to listen.” She went on to say, with respect to public health messaging, the first thing is to go with good questions and be willing to listen, because a preconceived message will likely be erroneous or not well received. Levine also emphasized that our ongoing ability to be effective in public health is based on relationships. “Until we believe that everyone matters and until we create those connections, it almost doesn’t matter what the message is, we are going to be ineffective.”
“Public health is not partisan, but it is political.”
For navigating the current political landscape,
2
- APHA cont'd on page 3
panelists highlighted the importance of keeping the goal of public health front of mind within our highly polarized environment. As Brown said, “We don’t have the luxury to get entrenched in the politics.” In public health, we work with everyone. Our job is to provide care and education for all, from the marginalized and underrepresented to even the contemptible (politically, socially, or otherwise). Importantly, it is not a requirement to agree with those for whom we provide care and education. As a public health field, we must remember what we are trying to do—our aim is to help and to build relationships, without which, our ability to be effective is diminished.
Dawes articulated a cogent, comprehensive outline for moving the ball forward for public health policy. Part art and part science, he discussed “having the savvy to tie health equity components to economic or national security arguments.” He stressed the need to communicate in a way that meets people where they are and to consider, “How do you talk to people in a way that makes them feel empowered and makes them feel like they are making their own decisions, and not like they are being talked down to?”
Community Engagement
Levine suggested that in public health the focus can often be on deficits, disease, or problems within a community, and that this is not always helpful, and to instead consider an asset orientation or a “well being approach.” While not avoiding what problems a community has, the focus can be what the community brings to the table, and that is how we achieve engagement. Levine noted that, “people define what well being means to them, we have to take all of that into consideration…physical, emotional, social, financial, spiritual.”
Resources
Several resources for further consideration were mentioned:
For streamlined public health messaging: Public Health Communications Collaborative
For public health communication tools: www.phrases.org
An example of collaboration between academia and community-based organizations: The Morehouse Model The visual note taking below highlights key points from the session and, remarkably, was created in live time during the panel discussion by Lauren Green of Dancing with Markers.
Image: Lauren Green of Dancing with Markers
(dancingwithmarkers.com Twitter: @dancing_markers)
- APHA cont'd from page 2 -3-
Decision-Making Given Incomplete Information and Evolving Evidence—a Broader Frame for Public Health Ethics Notes
from APHA 2022
Author: Madeline M. Roberts MPH, PhD
The closing general session of the 2022 APHA Conference was titled “Building Public Health Capacity Through an Ethical Lens to Address Social Challenges.” It began with a keynote presentation by Dr. Lisa Lee entitled “Public Health’s Ethical Lens” and concluded with a panel discussion including Drs. Howard Koh, Nancy Krieger, Rueben Warren, David Holtgrave, and Lisa Lee. Lee’s stated aim for the session was that the audience leave with “a common understanding of what we the public health profession mean when we say ‘ethics’.”
This session allowed the listener to zoom out and consider how the scope of ethics is much broader than simply doing the right thing. Rather, it is utilizing a framework and communicating clearly and openly about this framework to reach a decision in the face of conflicting values and incomplete information or evidence. Dr. Lee summarized this as taking the “best course of action given what we know at present,” and underscored the need to do this transparently for the communities involved.
In her presentation, Lee suggested that public health ethics is two things, both a noun and a verb. As a noun, it is moral governance, which she defined as “a constellation of values that motivate our work: equity, respect for human rights, common good, solidarity, and justice,” noting there are differences in values for different people. As a verb, as action we take, public health ethics is “reasoning and decision making in ethically challenging situations…the application of a decision making framework that helps us decide a course of action when
values conflict.” She went on to say that ethics is often not as simple as right versus wrong: “Even when we’re faced in public health with several not great choices, we still have to act, we still have to decide something, because public health if nothing else is a field of action.”
In nebulous situations, it is insufficient to lead with our instincts or what we personally think is best. Lee quoted Jim Swearengen as having said, “Professional judgment is the judgment of the profession, not the professional.” Lee offered that the same is true of public health ethics.
She concluded her presentation by discussing the collective moral compass of public health, the Public Health Code of Ethics, adopted by APHA in 2019 from a multi disciplinary task force. It contains six core values, eight considerations for public health decision making, and a framework for ethics in difficult decisions with conflicting values.
Interested in writing? The EpiMonitor is always looking for great articles to share with our readers Inquire with details info@epimonitor.net - Ethics cont'd on page 5 4
Table: Principles from The Public Health Code of Ethics
Core Values Considerations for Public Health Decision-Making
Professionalism and trust
Permissibility
Health and safety Respect Health justice and equity
Interdependence and solidarity
Human rights and civil liberties
Inclusivity and engagement
The panel discussion was moderated by Dr. Howard Koh, and included Drs. Nancy Krieger, David Holtgrave, Rueben Warren, and Lisa Lee. In her comments on ethical public health decision making and social determinants of health, Dr. Krieger noted that social determinants arise out of societal relationships of power and property. She suggested that a fundamental ethical duty in public health is to clearly name and call out those who make policies that do not allow for equity to exist. She also underscored the need for a more robust data infrastructure “to understand the health of people we need the data to have the evidence to make the decisions.”
Dr. Warren’s panel comments were helpful in articulating the gap between good intentions and measurable ethical action, “Everyone I know thinks they are ethical…we need to operationalize what that really means.” An operational definition of ethical conduct would allow us to move from reacting to ethical violations toward preventing them. Warren advocated for community engagement and discussed how public health ethics is more than just the principles of autonomy, benevolence, and justice: “The intention to do good is very different from doing good…doing good that you can measure.” In public health we should aim,
Reciprocity
Effectiveness
Responsible use of scarce resources
Proportionality
Accountability and transparency Public participation
as he put it, to “measurably do good beyond your intentions.”
Dr. Holtgrave discussed how part of transparency is being clear with the public about what we are aiming to achieve, especially when resources are limited and the need is great, “It’s important to highlight, what are those metrics that we are going to go after as a nation?” He gave an example from the Office of National Drug Control Policy where they have created a publicly viewable dashboard on the website for anyone to see what progress is being made and to what ends. He discussed the need for transparency in stating what the goals are, as well as the need to evaluate how we think about health disparities and health equity as it relates to stated goals.
In a field that deals with health promotion and protection for all manner of communities, and often centers underserved populations, this session was helpful in causing the listener to consider the difference between assuming one is ethical by simply being in public health and measurable ethical action. This conversation set the stage well for APHA 2023, for which the theme is “Overcoming Social and Ethical Challenges.”
■
-Ethics cont'd from page 4
-5-
The Epi Wayback Machine - Articles From Our
“Spaceship Earth”--McMichael’s Vision And The Importance
Research On Health Effects Of Climate Change
Author: Roger Bernier, MPH, PhD
[The following interview of Tony McMichael was carried out by the National Health and Medical Research Council in Australia in May 2008. The following is an edited version of the interview with excerpts here selected to help understand McMichael’s vision. The full interview can be accessed at http://tinyurl.com/jwyy99j]
Interviewer: Tony, I wonder if we could start with a bit of a macro view of the issue…could you just give us a picture of what the problem is that you see emerging.
Prof. McMichael: Well, I think the basic problem, that you've alluded to already, is that we really haven't got the full measure of what the significance, the impacts, of climate change, and indeed the various other global environment changes of which climate change is just part of the syndrome. We haven't got the measure of what they really signify. We've been fretting about the impact on the economy, disruption of economic activity, loss of jobs in some sectors. We worry about the threat to tourism, to physical infrastructure, to iconic species, and those things are all important.
But I think what we haven't done is to realise that now that we've started to disrupt the world's climate system and very many other of the great natural systems that are this planet's life support system, we are actually beginning to change the conditions of life on earth. And that's a big deal. That's what I would regard as the most important aspect of the climate change story. And we're just now starting to
Of
realise that as we begin to see that in addition to all the other impacts that climate change has already begun to have, we can see effects on human wellbeing, human health, in some parts of the world, and we're expecting that there'll be many more in the future. It includes infectious diseases as an important part of the story, but it's only part. There will be a whole range of adverse health effects.
Panel on Climate Change
Interviewer: You were part of the latest report from the Intergovernmental Panel on Climate Change. And what was the statement in there about this particular area?
Prof. McMichael: Well, the evidence has been stiffening up over the last decade as slowly an increasing number of epidemiologists and others have begun to engage in this question of how might climate change affect patterns of health and disease around the world. So this time around, this was the fourth five year cycle of the Intergovernmental Panel on Climate Change, the evidence was much broader and much stronger than it had been when I first got involved in the early 1990s when the story was really a new one and, indeed, one that wasn't much on the radar scheme for science at large, it was really the province of just a few marginal epidemiologists, who had a sense that this was going to become an important story. So we're now much more confident that we are beginning to get the measure of the risks to human health, but we also are beginning to
6 October
2014
Archives
- Climate cont'd on page 7
realise that in addition to trying to model the ways in which future climate change would affect patterns of disease around the world that in fact it's already beginning to happen in some parts of the world and we've got to work among ourselves as researchers, but work with government, with policy makers, to develop risk lessening strategies, what we call adaptive strategies.
Government Response
Interviewer: Now clearly governments all around the world are concerned and they need to have a response to these emerging issues. What's your take on what governments are trying to do in terms of preparedness scenarios for the emergence of these particular problems?
Prof. McMichael: Well, I should say at the outset that of course the problem is rather wider than infectious diseases. They capture a lot of our attention and we know that they're sensitive to climate. And it includes mundane things like food poisoning, salmonella food poisoning, also very temperature sensitive, and which we would expect to increase, particularly in poorer and more remote parts of this country. But we're also talking about the effect of increasing frequency and intensity of heatwaves and extreme weather events. We're talking about the effect of climate change on our fresh water supplies in this country, how that's going to continue to do damage to our rural sector, our food production. We know that the disruption of productive life in some parts of rural Australia is exacerbating mental health problems. There's always the tragedy of suicide lurking in the background as farmers lose livelihoods and families get displaced. So it's a pretty wide spectrum of risks to health that we have to be concerned about.
I think it would be fair to say that up until pretty recently our governments in this country and elsewhere have been slow to realise that this is an important part of the story. There's been an undue preoccupation with protecting local economies and not enough recognition that we now face actually a threat to our wellbeing, to our health, and in some parts of the world to our survival. And I must say in this part of the world there is also increasing concern in the background that the effects of climate change, along with population pressures and depletion of fresh water aquifers, exhaustion of agricultural soils, depletion of ocean fisheries, that all of these things will add up to severe food shortages, fresh water shortages, in the region around us, causing destabilisation, most probably, increased flow of environmental refugees. It could lead to lots of tensions and conflicts. And that, of course, inevitably has a range of adverse health consequences. So, you know, it's a big picture and governments really need to get serious about understanding that climate change carries huge risks increasingly over the coming decades to wellbeing and health of human populations.
Research Program
Interviewer: This past year you were awarded an Australian Fellowship from the NHMRC. What does that mean for you and what is the work that you're going to continue doing?
Prof. McMichael: Well, the first thing it means, of course, is it provides a wonderful opportunity for me to think within a five year time frame in the first instance, because I have funding for that period, and it's very generous funding, so it's an opportunity to develop a full blown program of research, particularly around the topic of climate change and human health. I must say the timing is also quite auspicious.
7
-Climate cont'd from page 6 Climate cont'd on page 8
Just within this past 12 months we've seen really an upturn, a very dramatic upturn, in awareness that climate change and health is an important research issue. We're now starting to see governments, and particularly health departments, responding to this. It's surprising that within the last 12 months there have been just so many workshops, conferences, consultations, on this topic at the state, national and international levels. So the timing is very good from my point of view.
What I'm in the process of doing now is recruiting a research team, developing this program, so we can engage not just within Australia, where our primary focus is, but also within the region at large begin to engage more with Asian and Pacific countries in developing a better understanding and making better use of comparative data from populations in different geographic and climatic circumstances, to get a better understanding of the risks that exist and a better capacity to model those risks, to understand how the disease patterns could change in future. Out of all of that, of course, to begin to work increasingly with government in the development of appropriate adaptive strategies to lessen risks to populations.
Future Oriented Research
Interviewer: It's quite an exciting time for epidemiology, because we interviewed on this series recently John Hopper, in Melbourne, and we discussed the comment about being an epidemiologist you're often looking backwards. But in fact you're going to be looking backwards and forward at the same time, so this is almost like a new dimension.
Prof. McMichael: It is. It's quite challenging in that respect, in that very often when you're dealing with environmental health problems the
agenda really is to understand from recent experience what the health risks have been and then to take appropriate action to eliminate that exposure. Now for something like climate change, of course, we can't realistically talk about eliminating the exposure, no matter what we do and we now understand this better than we did five or 10 years ago. No matter what we do, climate change is going to continue for the next few decades and I must say on current appearances and the difficulties national governments around the world are having in achieving a radical and progressive way of curtailing the problem, that it's going to escalate foreseeably for a number of decades. So this is really an unusual challenge for epidemiologists to have to engage not just in studying the world as it is around us at the moment, but trying to work with mathematicians, modellers, climate scientists and others, social scientists, to try and foresee the ways in which these risks will play out and to develop strategies for lessening those risks.
Inspiration
Interviewer: What inspired you to start on a research career? I note that you initially did a medical degree?
Prof. McMichael: Yes.
Interviewer: And I'm not sure whether you've ever practised medicine.
Prof. McMichael: I didn't practise it for very long, because I got caught up in the hurly-burly of student politics, and I moved to being the full time president of the National Union of Australian University Students in the year after I graduated in medicine. I did do some general practice in Victoria for a couple of years, but then I moved to Monash University to do a PhD
-Climate cont'd from page 7
- Climate cont'd on page 9 -8-
in the newly created Department of Social and Preventive Medicine. And it was during that time, actually, that I began to read some quite stimulating and ground breaking works in the area of environment and the consequences for human societies. I particularly remember a book by Paul and Anne Ehrlich on population resources and environment, published in about 1970, I think. And I had a friend who was editing a new newspaper his name was Richard Walsh; he was editing Nation Review. I offered to do a review of the book in that newspaper. He liked it and said, 'Would you like to write a regular column?' So then, whilst finishing my PhD, I wrote a column called 'Spaceship Earth' for the next couple of years, a weekly column.
Interviewer: And it was on?
Spaceship Earth
Prof. McMichael: Well, it was really on environmental issues, the spaceship earth notion that we live within this closed system, this little planet, and the damage that we do to the environment around us will have ways of coming back to bite us, and particularly as the scale of that damage begins to increase we will start to see systemic changes on a larger scale that would have wider ranging consequences for human health both now and into the future. And I suppose the climate change story which I started to notice about 15 years later, in the mid 1980s, was really an extension of that longstanding interest. And I saw it coming over the horizon and I thought this is, firstly, very interesting, I must find out about it, but secondly this looks to me as if it's going to have very important consequences for human health. So I got involved in reading about it. I remember when I was president of the Public Health Association of Australia in the late 1980s I actually concentrated on it in my presidential
address and said we need to take notice of this. Not many people did at that stage. But in the subsequent decade or two, it's really come clearly on to the agenda. And now it's fair square on the agenda and I'm hoping to really carry it forward with this new program of work.
Careers for Young People
Interviewer: It seems like a great time to think about a career for younger people in the area of epidemiology. It doesn't matter what their background is if you're a mathematician, as you say, or a computer modeller, or interested in the environment, this would be a great time to get into the game. Any advice to any younger people who are trying to think about what they could do in the future and why should they become an epidemiologist?
Prof. McMichael: Well, I think the first advice is don't be fainthearted. You don't have to imagine that you've got to have a lot of specialist skills. This is an area in which we're all learning. I've had to pick up ideas, information, from a range of disciplines in the last decade climate scientists, oceanographers, ecologist s. I've been listening to them all and reading their stuff. I didn't have specialised skills in those areas, but I've learnt enough to be able to integrate it now with my epidemiological research and to know with whom I should collaborate. I mean, this is an area in which we need multidisciplinary collaboration. So young people shouldn't imagine that they're entering a terrifying world of science in which they're going to be solely responsible for carrying out research. It'll be a team effort and it'll be good fun and it will be very important.
It's interesting for me to see that there's now
-Climate cont'd from page 8
- Climate cont'd on page 10 -9-
quite an upsurge in inquiries that my group is receiving from young people wanting to come on and do PhDs. We weren't getting this five years ago. But I think a number of young people can now see that this is not just a scientifically interesting and challenging area, but this is actually something that has enormous social relevance, enormous consequences for human futures, including the futures of themselves as young people and the families that they might have in future. So there's concern, there's engagement, and there's going to be enormous opportunity. These problems are going to escalate, unfortunately, for the next few decades. We're seriously understaffed. We need
a lot more young people coming in to work in the area. So I'd encourage anyone with an inkling of interest in this area to get into it. We need them and they would be doing something very interesting and hugely important.
Interviewer: On that upbeat note I thank you very much for your time and wish you well with your Australian Fellowship. It sounds like you're going to enjoy it. And all the best for the future.
Prof. McMichael: Thank you very much. It's going to be a challenging five years, but it's timely and I think we're going to do some good and important work. ■
-Climate cont'd from page 9
We Need Your Event Information We are currently preparing our annual epidemiology calendar edition and need your event information to include you in the list. We publish the following categories of events each year: Conferences, Short Courses, Summer Programs & Meetings To include your event please go to this link and provide us with the requested information. http://bit.ly/2SzL5iO If you have questions or want to purchase an ad for your event: Michele Gibson / michele@epimonitor.net -10-
Epi Crossword Puzzle – November 2022 The Wrote (or Edited) the Epi Book - Crossword Questions cont'd on page 12 -11Our crossword puzzle was created by by Dr. Richard Dicker A former CDC employee and not quite retired epidemiologist. For an online version go to: http://bit.ly/3H7YOaf For the solution to last month’s crossword please go to page 17. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
Across 1. U.S. President who also served as Supreme Court Chief Justice 5. It gets in your eyes, per the Platters 10. Marx Brothers, for example 14. Lotion ingredient
Honeydew is one 16. Sulk
Epidemiology, first edition
Long division term
First name of "Stairway to Heaven" band 21. " ___ the world's a stage..."
Watson's partner 23. The Medical Detectives 28. Compounds with C=C OH 30. Front man for the Maytals 31. Apple throwaway 32. Modern Epidemiology, first edition 36. Dory and fish like her 38. Logistic regression model's relation to data 39. Sing in the Alps 41. Control of Communicable Diseases Manual, latest edition 43. "Hold ___ your hat!" 44. Get up 46. Precursor blood cell
Essentials of Epidemiology in Public Health 52. Reluctant 53. Mad Hatter's drink 54. First name of recently retired WNBA star (no relation to long retired NBA star Larry) 57. Rock and Roll Hall of Fame State 58. Foundations of Epidemiology 62. 1040 is one 63. "It's not polite to ____ your lips..." 64. Lois at the Daily Planet 65. Start of "Jabberwocky" 66. Numbskulls 67. Yemen neighbor
Down 1. Shaq descriptor 2. Away from the wind 3. Many C. perfringens outbreaks are this type
Rishi Sunak's house number on Downing Street
Young salmon 6. Wine much maligned in the movie "Sideways" 7. Like the farmer MacDonald 8. Japanese garden swimmer 9. They are longer than hyphens, shorter than ems 10. Cathedral topper 11. Third category with Doric and Corinthian 12. Sundance's pal 13. Stir up 18. Needlefishes 22. Easy, like a job 24. Mournful poem 25. Type of shampoo 26. What you sing three times for the home team during seventh inning stretch 27. NY Giants Hall of Fame outfielder 28. "One Flew Over the Cuckoo's Nest" procedure (abbr.)
"Born a Crime" author
Money, in slang
Over and over and over and over (ugh) 35. They play in the Barclays Center
Huge hit 38. Fundraising org. that supports the big Bethesda HHS agency (abbr.)
His wife turned to look, then turned to salt
Part of the circumference of a circle
Lure
Stuff in a muffin
Up in the air
"Nobody can see the Great Oz, not nobody, not ____."
Currency used by the Nigeria FELTP
They have nuclei and electrons
Techie experts
Radius neighbor
Genesis garden
What Timothy Leary tripped on
Text abbr. for "This is what I think"
Place for a napkin
Insurance saleswoman on TV commercials
12 -Crossword Questions cont'd from page 11
15.
17.
19.
20.
22.
47.
4.
5.
29.
33.
34.
37.
40.
42.
45.
46.
47.
48.
49.
50.
51.
55.
56.
58.
59.
60.
61.
What We're Reading This Month
Editor's Note: All of us are confronted with more material than we can possibly hope to digest each month. However, that doesn't mean that we should miss some of the articles that appear in the public media on topics of interest to the epi community. Moving forward, the EpiMonitor will curate a list of some of the best articles we've encountered in the past month. See something you think others would like to read? Please send us a link at info@epimonitor.net and we'll add it to the list.
Ebola
♦
Morehouse epidemiologist talks about Ebola http://bit.ly/3gOgUTD
♦
Ebola is back and vaccines don’t work against it http://bit.ly/3u7OTtp
COVID-19
♦ Mark Litsitch discusses COVID 19 surveillance strategies http://bit.ly/3OISck8
♦ No evidence for “immunity debt” theories http://bit.ly/3u73CEV
♦
Depression after COVID symptoms to watch for, how to treat it http://bit.ly/3ijlmdI
♦
Repeat COVID 19 infections increase risk of organ failure and death http://bit.ly/3UeaCdM
♦
Shanghai Disney shuts over COVID 19, visitors unable to leave http://bit.ly/3u3AjDj
The Epidemiology Employment Picture
♦
Thousands of public health experts losing their jobs at a critical time http://bit.ly/3XI0hcQ
♦
Big city health departments warn of major shortage of epidemiologists http://bit.ly/3cEHX1o
13
- Reading cont'd on page 14
Race & Equity
♦
How racism skewed estimates of heart disease in women http://bit.ly/3gGH2jg
Wastewater
♦
Using wastewater based epidemiology to track viral disease dynamics http://bit.ly/3ES05PY
Other Public Health Topics
♦
How the global donkey skin trade risks spreading deadly diseases http://bit.ly/3VtIQe8
♦
Expert raises alarm about the possible link between autism and Tylenol http://bit.ly/3OGW6Ku
♦
Inside the public health campaign to stop polio in New York’s Jewish community http://bit.ly/3u5Nof4
♦
This UT scientist helped spare millions from COVID 19, now he’s unmasking other killer viruses http://bit.ly/3u5sg95
♦
Auto-immune diseases tied to the genes of Black Death survivors http://bit.ly/3VAU5l6
♦
The masks we’ll wear in the next pandemic http://bit.ly/3F7oouu
♦
Thawing permafrost exposes old pathogens and new hosts http://bit.ly/3F9Bjfn
What We're Reading This Month - con't from page 13
14
Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net
Honored: JoAnn E. Manson, MD, MPH, DrPH, Chief of the Division of Preventive Medicine at Brigham and Women’s Hospital, Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health at Harvard Medical School, and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, received the Alma Dea Morani Renaissance Woman Award in October 2022 for her pioneering contributions to women’s health, especially in the prevention of cardiovascular disease.
Stepping Down: Michelle Williams has announced that she is stepping down as Dean of the Harvard Chan School at the end of the 2022 23 academic year. Williams, a renowned epidemiologist who has published widely on maternal and child health, will remain on the faculty. After a year long sabbatical, she plans to resume the research, teaching, and mentoring that have long been at the center of her academic career.
Honored: Jennie H. Kwon, DO, an assistant professor of medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis, has received the 2022 Mid Career Scholarship Award from the Society for Healthcare Epidemiology of America (SHEA). The award honors clinicians and scientists who have been in practice for less than 15 years while also demonstrating “dedication and excellence in infection control and hospital epidemiology.”
Honored: Stephanie Shiau, PhD, MPH, an assistant professor in the Rutgers School of Public Health’s Department of Biostatistics and Epidemiology, received the 2022 Abraham Lilienfeld Award from the American Public Health Association Epidemiology Section. The award, which recognizes excellence in the teaching of epidemiology, was presented to Shiau at the organization’s annual meeting in Boston.
Do you have news about yourself, a colleague, or a student?
Notes
People -15-
on
Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net
Honored: Greg Rhee, PhD of the UCONN School of Medicine has been named a fellow of the American College of Epidemiology (ACE). Rhee is an interdisciplinary pharmaco epidemiologist and health services researcher in the fields of aging and mental health. His current research interests are interrelated and consist of mood disorders, dementias, and suicidality as well as cannabis and opioids. Methodologically, his expertise is grounded in population based comparative effectiveness and cost effectiveness research using large databases and also systematic reviews and meta analyses of existing studies.
Honored: Andrea Z. LaCroix PhDhas been named one of the 1,000 best researchers in the world. She is Distinguished Professor of Epidemiology and director of the Women’s Health Center of Excellence in the Herbert Wertheim School of Public Health & Human Longevity Science. Her work identifies modifiable factors associated with living longer and with intact mobility and cognition in older women and men. She also studies biomarkers of healthy longevity, such as epigenetic age acceleration. She leads several long term, large prospective studies and both preventive and treatment focused randomized controlled trials.
Awarded: Lisa Chasan-Taber MPH, ScD, chair of the University of Massachusetts Amherst Department of Epidemiology, has been awarded a five-year, $2.1 million grant from the National Institutes of Health (NIH) to continue research that aims to understand how physical and mental health during pregnancy can help predict cardiovascular and mental health disorders in middle age. Chasan-Taber will lead the project, collaborating with UMass Amherst neuroscientists Rebecca Spencer and Jerrold Meyer, professor and professor emeritus, respectively, of psychological and brain sciences.
Passed: Lewis Kuller MD Dr. Kuller, a top epidemiologist and a leading figure in preventive cardiology, could trace his interest in the field to when he was a medical resident in Brooklyn in the early 1960s, responding by ambulance to emergency calls when people had died suddenly of heart attacks at home or in the street. Appointed chairman of the epidemiology department at the University of Pittsburgh in 1972, he was also a professor there and a frequent investigator in clinical trials, as well the author of many journal articles. http://bit.ly/3OIPmLU
con't from page 15
Notes on People
Do you have news about yourself, a colleague, or a student?
-16-
people@epimonitor.net
Passed: Lee W. Riley MD At the time of his death, Riley was professor of epidemiology and infectious diseases and chair of the Infectious Diseases and Vaccinology Division at the UC Berkeley School of Public Health, as well as director of the Global Health Equity Scholars Program. Riley’s expansive research interests ranged from “slum” health to tuberculosis and from food borne pathogens including seminal work on E. coli to parasitic diseases. However, his true legacy is his generous mentorship of thousands of aspiring scientists and public health experts in the United States and around the globe. Their ongoing work serves as a testament to Riley’s ability to inspire and influence his students and collaborators. http://bit.ly/3AROXBc
Passed: Tom Meade, who has died aged 86, pioneered the field of cardiovascular epidemiology. His research, spanning five decades, gave medical science a vastly improved understanding of the biology of blood and the circulatory system, opening the door for targeted new heart disease treatments. In 1970, he became director of the newly created MRC Epidemiology and Medical Care Unit at Northwick Park in Harrow, north west London. In 2001 he became an emeritus professor of epidemiology at the London School of Hygiene and Tropical Medicine. http://bit.ly/3XGHvCD
People con't from page 16
o you have news about yourself, a colleague, or a student?
keep the
by
relevant
to us at this address for inclusion in our next issue.
Notes on
D
Please help The Epidemiology Monitor
community informed
sending
news
Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly. Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi Gram emails. For more information please contact:
Gibson
Michele
/ michele@epimonitor.net
Near Term Epidemiology Event Calendar
Every December The Epidemiology Monitor dedicates that issue to a calendar of events for the upcoming year. However that often means we don't have full information for events later in the upcoming year. Thus an online copy exists on our website that is updated regularly. To view the full year please go to: http://www.epimonitor.net/Events
The events that we are aware of for the next month follow below. December 2022 No
events listed 18 Answers to October Crossword We Need Your Event Information We are currently preparing our annual epidemiology calendar edition and need your event information to include you in the list. We publish the following categories of events each year: Conferences, Short Courses, Summer Programs & Meetings To include your event please go to this link and provide us with the requested information. http://bit.ly/2SzL5iO For more info contact: Michele Gibson / michele@epimonitor.net
Research Investigator MD/DO– Division of Health Services Research and Implementation Science (Open Rank)
The Department of Research and Evaluation (R&E), Kaiser Permanente Southern California (KPSC) is recruiting candidates for a Research Scientist/MD Investigator in the Division of Health Services Research and Implementation Science. This is an open rank Research Scientist (equivalent to an Assistant, Associate or Full Professor) position. This position is an ideal opportunity for a physician scientist to conduct and lead high quality health services research that results in improvements to patient care, with the option to maintain a part time clinical practice with the Southern California Medical Group (SCPMG). Health services research can include the comparative effectiveness of delivery systems; patient centered care; health care for people with diverse backgrounds; as well as health care access, utilization, and dissemination and implementation of findings and practices. Current areas of high priority for KPSC include cancer care, cardiovascular health, mental health and wellness, and health equity across these domains.
Qualifications: Medical Doctoral Degree (MD) or Doctor of Osteopathic Medicine (DO) with post doctoral research training in health services, epidemiology, health economics, public health, healthcare administration, or related fields or equivalent training and mastery preferred. Competent in advanced research methods, including statistical techniques and study designs commonly used in health services research, implementation science, epidemiology, behavioral research, economics, or related fields. Experience or interest in partnering with operational leadership across broad clinical areas within a learning health system. Must be able to consistently demonstrate the knowledge, skills, abilities, and behaviors necessary to provide superior and culturally sensitive service to all.
The successful candidate will be expected to:
• Design, develop, and direct a blended internally and externally funded research program that is aligned with clinical practice resulting in the translation of results directly to patient care.
• Lead or co lead oversight of the Care Improvement Research Team (CIRT) embedded research portfolio (Research Scientist Levels II-III only).
• Collaborate with clinical investigators within R&E and with external investigators in health care and academic settings, to advance knowledge in the diagnosis, treatment, and outcomes for various conditions across diverse populations.
• Provide service to the scientific community through reviewing manuscripts for publication, serving on editorial boards, and grant review panels.
• Present at national and international scientific meetings.
• Maintain awareness of scientific developments within area of expertise, both in terms of new methodology and new research activities.
• Serve on and may chair departmental committees based on experience and expertise.
The candidate may also serve as a faculty in the Kaiser Permanente Bernard J. Tyson School of Medicine and have the opportunity to teach and mentor students. This position will include a core support package for the successful applicant that can be used to conduct pilot studies that leverage existing infrastructure to facilitate the development of an extramurally funded research program. This support includes staffing for administrative tasks, programming and analysis, and research support as well as funding for non personnel related costs.
KPSC is a leading integrated health care organization with 4.8 million members of diverse race/ethnicity living throughout Southern California. They are attended by over 7,800 physicians practicing in an integrated, pre paid delivery system that provides comprehensive health care and pharmaceutical benefits to members of the non profit Kaiser Foundation Health Plan and Hospitals. KPSC has deployed an extensive clinical information system, including a fully automated medical record system. A description of R&E is available on the web (http://www.kp scalresearch.org/). The Department is located in Pasadena, a community of 143,000 residents and the home of the California Institute of Technology, the Rose Bowl, the Jet Propulsion Lab, and other historical and cultural sites. Information about the community can be found online at www.visitpasadena.com. Pasadena is in the San Gabriel Valley 15 minutes north of downtown Los Angeles in sunny southern California.
For more information or to apply for this position, please visit the Kaiser Permanente job website at http://www.kaiserpermanentejobs.org and search Job Numbers: 1078457 (Research Investigator I MD), 1078444 (Research Investigator II MD), or 1078430 (Research Investigator III MD) in the keyword field. Inquiries may be directed to Dr. Huong Nguyen at the research recruitment mailbox (email: Research Recruitment@kp.org). Principals only.
KPSC is an Equal Opportunity/Affirmative Action Employer and offers a comprehensive compensation package, including employer paid medical, dental and coverage for eligible dependents. Competitive wages, generous paid time off and a comprehensive retirement plan are just part of the exceptional benefits offered to Kaiser Permanente employees.
Post-Doctoral Research Fellow, Infectious Disease Epidemiology
The Department of Research and Evaluation (R&E) of Kaiser Permanente Southern California (KPSC) is seeking a Post Doctoral Research Fellow interested in infectious disease epidemiology and vaccine safety and effectiveness.
The R&E of KPSC conducts high quality research involving large, diverse populations, providing timely evidence to decision makers and the public. The research team has expertise and experience in performing a vast array of infectious disease research, including vaccine research studies. Studies range from large, multisite epidemiologic studies on a variety of topics including antibiotic resistance, hospital infections, tuberculosis, COVID 19, and vaccine preventable diseases, to Phase IV vaccine post licensure observational studies. The research team works with partners from government, industry, academia, and other health care systems. Our vaccine research consists of topics including vaccine safety and effectiveness, vaccines in special populations (e.g., pregnant women, immunocompromised individuals), vaccine uptake and compliance with recommendations, and methodologies for vaccine studies. Findings from studies guide KPSC clinical care improvement efforts, as well as immunization policy and regulatory decisions and provide the public with information regarding risks and benefits of immunization.
Essential Responsibilities:
Designs, develops and directs well defined research with supervision from a R&E Research Scientist. Prepares grant proposals and publications independently and collaboratively. Provides consultation and direction to programmer/analysts with regard to data management and analysis strategies. May perform subject assessments or chart reviews or provide direction to research support staff performing these tasks. Submits abstracts to and presents papers at national scientific meetings. Seeks consultation from research scientists for specific scientific and administrative issues. Participates in R&E department meetings and projects as appropriate.
Preferred Qualifications:
Doctoral degree (Ph.D., Dr.P.H., M.D., Sc.D.) in epidemiology, preferably in infectious disease epidemiology, or clinical doctoral degree + master's degree with formal research training in epidemiology. Track record of publication in the peer reviewed literature. Research experience in infectious disease epidemiology or vaccine safety and effectiveness. Competent in advanced research methods, including statistical techniques and study design commonly used in epidemiologic research or related fields.
KPSC is a leading managed health care organization with 4 million members of diverse race/ethnicity living throughout Southern California. They are attended by over 6,000 physicians practicing in an integrated, pre paid delivery system that provides comprehensive health care and pharmaceutical benefits to members of the non profit Kaiser Foundation Health Plan and Hospitals. KPSC has deployed an extensive clinical information system, including a fully automated medical record system. A description of the Department of Research & Evaluation is available on the web (http://www.kp scalresearch.org/). It is the home to nearly 30 doctorally prepared investigators and over 400 support staff. The Department is located in Pasadena, a community of 143,000 residents and the home of the California Institute of Technology, the Rose Bowl, the Jet Propulsion Lab, and other historical and cultural sites. Information about the community can be found online at www.visitpasadena.com Pasadena is in the San Gabriel Valley 15 minutes north of downtown Los Angeles in sunny southern California.
This one year renewable position (funding and performance dependent) will provide mentored experience in field work, proposal development and scientific publication, designed to prepare the incumbent for a productive career as an independent researcher.
KPSC is an Equal Opportunity/Affirmative Action Employer and offers a comprehensive compensation package, including employer paid medical, dental and coverage for eligible dependents. Competitive wages, generous paid time off and a comprehensive retirement plan are just part of the exceptional benefits offered to Kaiser Permanente employees.
For immediate consideration, interested candidates should submit their letter of interest, CV and references to Dr. Kristi Reynolds, Director of Epidemiologic Research (email: allan.slatkin@kp.org) and by Kaiser Permanente Job Posting 961068 Website (Click Here) or visit the Kaiser Permanente job website at https://www.kaiserpermanentejobs.org/ and search 961068 in the keyword field.
Post-Doctoral Research Fellow, Vaccine Safety and Effectiveness
The Department of Research and Evaluation (R&E) of Kaiser Permanente Southern California (KPSC) is seeking a Post Doctoral Research Fellow interested in infectious disease epidemiology and vaccine safety and effectiveness.
The KPSC Center for Vaccine Safety and Effectiveness Research high quality research involving large, diverse populations, providing timely evidence to decision makers and the public. The Center is part of the Department of Research & Evaluation, based in Pasadena, California. The research team has expertise and experience in performing a vast array of vaccine research studies, ranging from epidemiologic studies of vaccine preventable diseases to Phase IV post licensure observational studies. The research team works with partners from government, industry, academia, and other health care systems to conduct important research on topics such as vaccine safety and effectiveness, vaccines in special populations (e.g., pregnant women, immunocompromised individuals), vaccine uptake and compliance with recommendations, and methodologies for vaccine studies. Findings from the Center’s studies guide immunization policy and regulatory decisions and provide the public with information regarding risks and benefits of immunization.
Essential Responsibilities:
Designs, develops and directs well-defined research with supervision from a R&E Research Scientist. Prepares grant proposals and publications independently and collaboratively. Provides consultation and direction to programmer/analysts with regard to data management and analysis strategies. May perform subject assessments or chart reviews or provide direction to research support staff performing these tasks. Submits abstracts to and presents papers at national scientific meetings. Seeks consultation from research scientists for specific scientific and administrative issues. Participates in R&E department meetings and projects as appropriate.
Preferred Qualifications:
Doctoral degree (Ph.D., Dr.P.H., M.D., Sc.D.) in epidemiology, preferably in infectious disease epidemiology, or clinical doctoral degree + master's degree with formal research training in epidemiology. Track record of publication in the peer-reviewed literature. Research experience in infectious disease epidemiology or vaccine safety and effectiveness. Competent in advanced research methods, including statistical techniques and study design commonly used in epidemiologic research or related fields.
KPSC is a leading managed health care organization with 4 million members of diverse race/ethnicity living throughout Southern California. They are attended by over 6,000 physicians practicing in an integrated, pre paid delivery system that provides comprehensive health care and pharmaceutical benefits to members of the non profit Kaiser Foundation Health Plan and Hospitals. KPSC has deployed an extensive clinical information system, including a fully automated medical record system. A description of the Department of Research & Evaluation is available on the web (http://www.kp scalresearch.org/). It is the home to nearly 30 doctorally prepared investigators and over 400 support staff. The Department is located in Pasadena, a community of 143,000 residents and the home of the California Institute of Technology, the Rose Bowl, the Jet Propulsion Lab, and other historical and cultural sites. Information about the community can be found online at www.visitpasadena.com Pasadena is in the San Gabriel Valley 15 minutes north of downtown Los Angeles in sunny southern California.
This one year renewable position (funding and performance dependent) will provide mentored experience in field work, proposal development and scientific publication, designed to prepare the incumbent for a productive career as an independent researcher.
KPSC is an Equal Opportunity/Affirmative Action Employer and offers a comprehensive compensation package, including employer paid medical, dental and coverage for eligible dependents. Competitive wages, generous paid time off and a comprehensive retirement plan are just part of the exceptional benefits offered to Kaiser Permanente employees.
For immediate consideration, interested candidates should submit their letter of interest, CV and references to Dr. Kristi Reynolds, Director of Epidemiologic Research (email:sole.x.cardoso@kp.org) and by Kaiser Permanente Job Posting 1085595 Website (Click Here) or visit the Kaiser Permanente job website at https://www.kaiserpermanentejobs.org/ and search 1085595 in the keyword field.
Post-Doctoral
Research
Fellow, Cardiovascular Pharmacoepidemiology
The Department of Research and Evaluation (R&E) of Kaiser Permanente Southern California (KPSC) is seeking a Post Doctoral Research Fellow interested in pharmacoepidemiology and cardiovascular disease research.
Scientists in the Department of R&E conduct research involving large, diverse populations, providing timely evidence to decisionmakers and the public. The research teams have expertise and experience in performing a vast array of population based cardiovascular disease research and pharmacoepidemiology studies. Projects include large, multisite cardiovascular epidemiologic studies on prevention, incidence, treatment, medication adherence, comparative effectiveness/safety, health resource utilization, and outcomes research. The overarching goal of these studies is to use our large membership and extensive data to generate results that will improve care and contribute to scientific knowledge about cardiovascular outcomes.
The research teams work with partners from government, industry, academia, and other health care systems.
This one year renewable position (funding and performance dependent) will provide mentored experience in field work, proposal development and scientific publication, designed to prepare the incumbent for a productive career as an independent researcher.
Essential Responsibilities:
Designs, develops and directs well defined research with supervision from a R&E Research Scientist.
Prepares grant proposals and publications independently and collaboratively.
Provides consultation and direction to programmer/analysts with regard to data management and analysis.
May perform subject assessments or chart reviews or provide direction to research support staff performing these tasks.
Submits abstracts to and presents papers at national scientific meetings.
Seeks consultation from research scientists for specific scientific and administrative issues.
Participates in R&E department meetings and projects as appropriate.
Preferred Qualifications:
Doctoral degree (Ph.D., Dr.P.H., Sc.D.) in epidemiology, preferably in pharmacoepidemiology or cardiovascular disease epidemiology, health economics and outcomes research, health services research, or a clinical doctoral degree (M.D., Pharm.D.) + master's degree with formal research training in epidemiology and/or biostatistics.
Track record of publication in the peer reviewed literature.
Research experience in epidemiology or biostatistics and track record of publishing in peer reviewed journals.
Competent in advanced research methods, including statistical techniques and study design commonly used in epidemiologic research or related fields.
A description of the Department of Research & Evaluation is available on the web at http://kp.org/research It is home to 30+ doctorally prepared investigators and over 400 support staff. The Department is located in Pasadena, California, a community of 140,000 residents and the home of the California Institute of Technology, the Rose Bowl, the Jet Propulsion Lab, and other historical and cultural sites. Information about the community can be found at https://www.visitpasadena.com
KPSC is an Equal Opportunity/Affirmative Action Employer and offers a comprehensive compensation package, including employer paid medical, dental and coverage for eligible dependents. Competitive wages, generous paid time off and a comprehensive retirement plan are just part of the exceptional benefits offered to Kaiser Permanente employees.
For immediate consideration, interested candidates should submit their letter of interest, CV and references to Dr. Kristi Reynolds, Director of Epidemiologic Research (email:sole.x.cardoso@kp.org) and by Kaiser Permanente Job Posting 1085654 Website (Click Here) or visit the Kaiser Permanente job website at https://www.kaiserpermanentejobs.org/ and search 1085654 in the keyword field.
Multiple Faculty Emergency Medicine
The University of California, Davis, School of Medicine, Department of Emergency Medicine is conducting a faculty search at the Assistant/Associate/Professors in the Adjunct or In Residence track.
Applicants must possess a doctoral degree in health, epidemiology, or another related discipline. An applicant completing their doctoral degree must have proof of completion prior to hiring. Additional training during a formal post-doctoral fellowship or substantial prior research experience in the field is preferrable. A track record of independent funding is also highly desirable, as is a research focus in clinical medicine or clinical epidemiology. We especially welcome applicants whose research, teaching, and community outreach demonstrably attest to their commitment to inclusion of under-represented and/or non-majority individuals.
The UC Davis Department of Emergency Medicine provides comprehensive emergency services to a large local urban and referral population as a Level One Trauma Center, Comprehensive Stroke Center, and EMS base station. The Department of Emergency Medicine has a strong research infrastructure and consistently ranks near the top nationally in NIH funding. Primarily, the candidate will be expected to develop and maintain an active research portfolio that is externally funded. Secondarily, the candidate will be expected to participate in Departmental education, administrative, and mentorship activities commensurate to academic rank.
For full consideration, please consult the link below for apply by dates. This recruitment will be open until filled through June 30, 2023. To apply please upload the following: letter of interest, curriculum vitae, and a statement of contributions to diversity to: https://recruit.ucdavis.edu/apply/JPF05194 . All files should be in PDF format.
Laurin, M.D., Professor and Search Committee Chair, (eglaurin@ucdavis.edu)
UC Davis Department of Emergency Medicine
2315 Stockton Boulevard, PSSB 2100, Sacramento, CA 95817
Erik
Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly. Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi-Gram emails. For more information please contact: Michele Gibson / michele@epimonitor.net
Assistant Professors Epidemiology, Data Science & Public Health
The Office of Public Health Studies (OPHS) is part of the Thompson School of Social Work & Public Health. OPHS offers specializations in epidemiology, health policy and management, Native Hawaiian and Indigenous health, and social and behavioral health sciences. Degrees offered include the bachelor of arts (BA), master of public health (MPH), master of science (MS) in public health, and doctor of philosophy (PhD). The OPHS is seeking an Assistant Professor in Epidemiology to teach undergraduate and graduate public health students and other health professionals to begin August 2023. Applicants who are ABD will be considered, however, degree requirements must be met by the effective date of appointment.
Assistant Professor Epidemiology & Public Health (Position # 0082227) Apply Here: http://bit.ly/3UXyIKV Inquiries: Dr. Eric Hurwitz, ehurwitz@hawaii.edu More Info: http://bit.ly/3AVR33f
Assistant Professor – Epidemiology & Data Science (Position # 0083002) Apply Here: http://bit.ly/3tMAKS2 Inquiries: Dr. Jane Chung-Do, chungjae@hawaii.edu More Info: http://bit.ly/3XMH0r4
Founded in 1907, the University of Hawaiʻi at Mānoa has students and faculty come from across the nation and the world to take advantage of its unique research opportunities, diverse community, and beautiful landscape. UH Mānoa is classified by the Carnegie Foundation as an R1 research institution and also holds the status as a land, sea and space-grant institution. Consistently ranked a "best value" among U.S. colleges and universities, our students have a unique multicultural global experience in a Hawaiian place of learning-truly like no place else on earth.
EEO/AA, Clery Act, ADA
Assistant / Associate Professor Tenure-Track
The Department of Epidemiology within the Geisel School of Medicine at Dartmouth, and the Dartmouth Cancer Center invites applications for a tenure-track position as Assistant or Associate Professor. We seek applicants to lead an independent, innovative research program in cancer epidemiology, including but not limited to cancer prevention, etiology, early detection, survivorship, health disparities, molecular epidemiology, environmental epidemiology, or lifestyle/behavioral research. Dartmouth Cancer Center offers a dynamic and interactive environment with a commitment to research excellence. The faculty appointment will be in the Department of Epidemiology, with membership in the Cancer Population Sciences research program.
Dartmouth is highly committed to fostering a diverse and inclusive population of students, faculty, and staff. We seek applicants who work effectively with individuals from all backgrounds, including but not limited to: racial and ethnic minorities, women, those who identify with LGBTQ+ communities, persons with disabilities, are from lower income backgrounds, veterans, and first generation college graduates. Applicants should state in their cover letter how their teaching, research, service, and/or life experiences prepare them to advance Dartmouth’s commitments to diversity, equity, and inclusion.
Qualifications
Candidates must have a Ph.D. and/or M.D. degree and relevant postdoctoral research experience.
Application Instructions
Applicants should upload a cover letter, a curriculum vitae (without impact factors), a description of proposed research (3 pages or less), a teaching statement, and a statement on how their teaching, research, service, and/or life experiences prepare them to advance diversity, equity, and inclusion at Dartmouth through this interfolio https://apply.interfolio.com/99545 link. Three referees should provide letters of recommendation. Consideration of applications will begin on November 15th, 2022, and continue until the position is filled.
For further information check here: http://epimonitor.net/2022 3549 Epidemiology Job Opening.htm
FIFTEEN OPEN FACULTY POSITIONS IN EPIDEMIOLOGY
The Department of Epidemiology and Environmental Health, in the School of Public Health and Health Professions (SPHHP) at the University at Buffalo (UB) is excited to announce openings for fifteen (15) full time faculty. The positions are all fully funded by New York State and are calendar year (12 month) positions in our Graduate Public Health Program. The successful candidates will join a University wide multidisciplinary team of public health faculty and be part of the Department of Epidemiology and Environmental Health. Detailed information about each position can be found below and on our website: www.ubjobs.buffalo.edu.
♦ New Center for Climate Change and Health Equity ◦
Number of positions: 5 ◦
Posting number & link: F220199 www.ubjobs.buffalo.edu/postings/38164 ♦
One director position: to lead the new center ♦
Full/Associate Professor (tenure eligible) with funding and a history of leadership in areas including health effects of climate change such as environmental epidemiology, climate science, modeling, and environmental justice/health disparities. ♦
Four Full/Associate Professor (tenure eligible) positions: senior leadership team for new center ♦
To work with the center director and team of interdisciplinary faculty from within the department and across the university to write proposals and develop the center ♦
Candidates should have funding and expertise in the health effects of climate change including environmental epidemiology, climate science, modeling, and environmental justice/health disparities.
♦
Maternal/Child Health; Perinatal/Reproductive Epidemiology Research ◦
Number of positions: 2 ◦
Posting number & link: F220199 www.ubjobs.buffalo.edu/postings/38164 ◦
Two Assistant/Associate Professor (tenure track) positions
♦
♦
Primary focus on research with contributions to teaching and service missions of the SPHHP
Aging Research (including, but not limited to, frailty, cancer,women's health, cognition/dementia) ◦
Number of positions: 2 ◦
Posting number & link: F220239 www.ubjobs.buffalo.edu/postings/38791 ◦
Two Full Professor (tenure eligible) positions with funding and a history of leadership in aging research. We are keenly interested in candidates with established research teams and welcome team member applications to our Asst/Assoc level posting below.
♦
Health, Infectious or Chronic Disease, Aging, Cancer, Women's Health, Health Disparities and/or Advanced Epidemiologic Research ◦
Number of positions: 6 ◦
Posting number & link: F220199 www.ubjobs.buffalo.edu/postings/38164 ◦
Six Assistant/Associate Professor (tenure track) positions
♦
Primary focus on research with contributions to teaching and service missions of the SPHHP
Candidates must have a doctoral degree (PhD, MD, DDS, PharmD, etc.) in a public health discipline or a related field.
Candidates must apply through the UB Online system at www.ubjobs.buffalo.edu Applications will be considered as they are received. For best consideration, please apply as soon as possible. Questions about any of the positions can be directed to: Jennifer Forgnone at forgnone@buffalo.edu.
Additional details: http://bit.ly/3GWfdOW
Monitor in a Digital Version is available FREE to subscribers The Epidemiology Monitor is available exclusively online in the same familiar print format subscribers were
to, and they can read through the publication on their electronic devices in the same manner they did with the print version.
you can download and save copies of
Monitor for easy future access. This digital publication format provides: ► Easier access to information that is more timely ► Publication alerts via email ► Embedded hot links in articles ► Full color advertising ► Wider circulation for advertisers SUBSCRIBE FOR FREE TODAY AT: http://epimonitor.net/Subscribe.htm The Epidemiology Monitor ISSN (2833 1710) is published monthly Editorial Contributors Katelyn Jetelina, PhD, MPH Editor and Publisher Operations Christopher Jetelina Operations Manager Advertising Sales Michele Gibson sales@epimonitor.net Advertising Rates All ads listed below also include a banner ad on our website and in our EpiGram emails. Full Page $1,315 7.5”w x 10” h Half Page $985 7.5”w x 4.75” h Website Ad $545 / mo. Includes a banner ad in our EpiGram emails Multi-month discounts available upon request. Contact Us The Epidemiology Monitor info@epimonitor.net
The Epidemiology
accustomed
In addition,
The Epidemiology